CardiologyOnline.net

Cardiology Xagena

Xagena Mappa
Medical Meeting
Reumabase.it
Gastrobase.it

Search results for "Evolocumab"

Amgen has announced that the phase 3 GAUSS-2 ( Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-2 ) trial evaluating Evolocumab in patients with high cholesterol w ...


New detailed data from the phase 3 YUKAWA-2 study evaluating Evolocumab ( Repatha ), a novel investigational cholesterol-lowering medication, in Japanese patients with high cardiovascular risk and hig ...


Evolocumab ( Repatha ), a PCSK9 inhibitor, has shown to dramatically lower levels of low-density lipoprotein ( LDL), and also the risk of cardiovascular events in patients with existing heart or vascu ...


New data from Evolocumab ( Repatha ) cardiovascular outcomes trial ( FOURIER ) were presented at the 2017 National Lipid Association Scientific Sessions, which showed that Evolocumab consistently and ...